• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用小鼠模型的基于培养的快速低成本毛霉病诊断方法。

Rapid and Low-Cost Culture-Based Method for Diagnosis of Mucormycosis Using a Mouse Model.

作者信息

Vaezi Afsane, Fakhim Hamed, Ilkit Macit, Faeli Leila, Fakhar Mahdi, Alinejad Vahid, Wiederhold Nathan P, Badali Hamid

机构信息

Invasive Fungi Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

出版信息

Front Microbiol. 2020 Mar 20;11:440. doi: 10.3389/fmicb.2020.00440. eCollection 2020.

DOI:10.3389/fmicb.2020.00440
PMID:32265876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7099612/
Abstract

Prompt and targeted antifungal treatment has a positive impact on the clinical outcome of mucormycosis; however, current diagnostic tools used in histopathology laboratories often fail to provide rapid results. Rapid culture-based strategies for early diagnosis of infections, which may influence treatment decisions, are urgently needed. Herein, we evaluated a microculture assay for the early diagnosis of mucormycosis in an immunocompetent murine model of disseminated infection, by comparing it with traditional diagnostic methods. The assay specificity was assessed using blood ( = 90) and tissue ( = 90) specimens obtained from mice infected with using different inoculum sizes [1 × 10, 1 × 10, and 1 × 10 colony forming units (CFUs)/mouse] and blood ( = 15) and tissue specimens ( = 15) from uninfected mice. Surprisingly, 26 of 90 (28.9%) blood samples revealed positive results by microculture, whereas all blood samples were negative when assayed by conventional culture. The overall positive conventional culture rate for the mouse tissue (kidney) samples was 31.1% (28/90). The calculated sensitivity for kidney microculture was 98.8% [95% confidence interval (CI) 96.6-100], with an assay specificity of 100%. Hence, the microculture assay may be useful for rapid culturing and diagnosis of mucormycosis caused by directly in blood and tissue samples. Hence, this method may allow for the timely administration of an appropriate treatment.

摘要

及时且有针对性的抗真菌治疗对毛霉菌病的临床结果有积极影响;然而,组织病理学实验室目前使用的诊断工具往往无法提供快速结果。迫切需要基于培养的快速策略来早期诊断感染,这可能会影响治疗决策。在此,我们通过将一种微量培养测定法与传统诊断方法进行比较,评估了其在免疫功能正常的播散性感染小鼠模型中对毛霉菌病的早期诊断能力。使用从感染不同接种量[1×10、1×10和1×10菌落形成单位(CFU)/小鼠]的小鼠获得的血液(n = 90)和组织(n = 90)标本以及未感染小鼠的血液(n = 15)和组织标本(n = 15)评估该测定法的特异性。令人惊讶的是,90份血液样本中有26份(28.9%)通过微量培养显示阳性结果,而通过传统培养检测时所有血液样本均为阴性。小鼠组织(肾脏)样本的传统培养总体阳性率为31.1%(28/90)。计算得出肾脏微量培养的敏感性为98.8%[95%置信区间(CI)96.6 - 100],测定特异性为100%。因此,微量培养测定法可能有助于直接在血液和组织样本中快速培养和诊断由引起的毛霉菌病。因此,这种方法可能允许及时给予适当的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa16/7099612/487363fef9ab/fmicb-11-00440-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa16/7099612/918cad121ee4/fmicb-11-00440-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa16/7099612/2a4376cf83dc/fmicb-11-00440-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa16/7099612/727f33792c85/fmicb-11-00440-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa16/7099612/487363fef9ab/fmicb-11-00440-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa16/7099612/918cad121ee4/fmicb-11-00440-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa16/7099612/2a4376cf83dc/fmicb-11-00440-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa16/7099612/727f33792c85/fmicb-11-00440-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa16/7099612/487363fef9ab/fmicb-11-00440-g004.jpg

相似文献

1
Rapid and Low-Cost Culture-Based Method for Diagnosis of Mucormycosis Using a Mouse Model.使用小鼠模型的基于培养的快速低成本毛霉病诊断方法。
Front Microbiol. 2020 Mar 20;11:440. doi: 10.3389/fmicb.2020.00440. eCollection 2020.
2
Development of a Monoclonal Antibody and a Serodiagnostic Lateral-Flow Device Specific to (Syn. ), the Principal Global Agent of Mucormycosis in Humans.开发一种针对人类毛霉病主要全球病原体(同义词: )的单克隆抗体和一种血清诊断侧向流动装置。
J Fungi (Basel). 2022 Jul 21;8(7):756. doi: 10.3390/jof8070756.
3
PCR-Based Approach Targeting Mucorales-Specific Gene Family for Diagnosis of Mucormycosis.基于聚合酶链反应(PCR)的方法针对黏菌类特异性基因家族用于毛霉病的诊断。
J Clin Microbiol. 2018 Sep 25;56(10). doi: 10.1128/JCM.00746-18. Print 2018 Oct.
4
Comparative immunopathogenesis in a murine model of inhalative infection with the mucormycetes Lichtheimia corymbifera and Rhizopus arrhizus.吸入性感染毛霉菌属亮菌和根霉菌属犁头霉的鼠模型中的比较免疫发病机制。
PLoS One. 2020 Jun 17;15(6):e0234063. doi: 10.1371/journal.pone.0234063. eCollection 2020.
5
Identification of Mucorales in patients with proven invasive mucormycosis by polymerase chain reaction in tissue samples.聚合酶链反应在组织样本中鉴定确诊为侵袭性毛霉病的患者中的毛霉目。
Mycoses. 2018 Dec;61(12):909-915. doi: 10.1111/myc.12837. Epub 2018 Aug 28.
6
Diagnosis of mucormycosis using a simple duplex PCR assay: Analysis of 160 clinical samples from COVID-19 patients.采用简单双重 PCR 检测方法诊断毛霉菌病:对 160 例 COVID-19 患者的临床样本进行分析。
Med Mycol. 2023 Sep 4;61(9). doi: 10.1093/mmy/myad091.
7
[Not Available].[无可用内容]。
J Mycol Med. 2017 Dec;27(4):586-588. doi: 10.1016/j.mycmed.2017.10.001. Epub 2017 Nov 7.
8
Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients.定量聚合酶链反应检测血清循环 DNA 对免疫功能低下患者中毛霉病的早期诊断。
Clin Infect Dis. 2013 May;56(10):e95-101. doi: 10.1093/cid/cit094. Epub 2013 Feb 18.
9
Development of a Combat-Relevant Murine Model of Wound Mucormycosis: A Platform for the Pre-Clinical Investigation of Novel Therapeutics for Wound-Invasive Fungal Diseases.创伤性毛霉菌病的战斗相关小鼠模型的建立:一种用于伤口侵袭性真菌病新型疗法临床前研究的平台。
J Fungi (Basel). 2024 May 20;10(5):364. doi: 10.3390/jof10050364.
10
VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection.VT-1161可保护免疫抑制小鼠免受米根霉变种感染。
Antimicrob Agents Chemother. 2015 Dec;59(12):7815-7. doi: 10.1128/AAC.01437-15. Epub 2015 Sep 14.

引用本文的文献

1
Rhino-orbital-cerebral mucormycosis in acute myeloid leukemia patients: a case series from Sri Lanka.急性髓系白血病患者的鼻眶脑毛霉菌病:来自斯里兰卡的病例系列
BMC Infect Dis. 2024 Dec 26;24(1):1465. doi: 10.1186/s12879-024-10334-y.
2
Hyphae of and Are More Virulent and Resistant to Antifungal Agents Than Sporangiospores In Vitro and in .在体外和体内,毛霉属和根霉属的菌丝比孢子囊孢子更具毒性且对抗真菌剂更具抗性。
J Fungi (Basel). 2023 Sep 23;9(10):958. doi: 10.3390/jof9100958.
3
New insights on mucormycosis and its association with the COVID-19 pandemic.

本文引用的文献

1
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.全球毛霉病诊断和管理指南:欧洲医学真菌学会联合会与真菌感染研究组教育和研究联盟合作开展的一项倡议。
Lancet Infect Dis. 2019 Dec;19(12):e405-e421. doi: 10.1016/S1473-3099(19)30312-3. Epub 2019 Nov 5.
2
Global Epidemiology of Mucormycosis.毛霉病的全球流行病学
J Fungi (Basel). 2019 Mar 21;5(1):26. doi: 10.3390/jof5010026.
3
Recent advances in the understanding and management of mucormycosis.
关于毛霉菌病及其与新冠疫情关联的新见解。
Future Sci OA. 2021 Dec 16;8(2):FSO772. doi: 10.2144/fsoa-2021-0122. eCollection 2022 Feb.
毛霉病诊治的最新进展
F1000Res. 2018 Sep 7;7. doi: 10.12688/f1000research.15081.1. eCollection 2018.
4
Recent advances in the molecular diagnosis of mucormycosis.近年来,接合菌病的分子诊断取得了新进展。
Expert Rev Mol Diagn. 2018 Oct;18(10):845-854. doi: 10.1080/14737159.2018.1522250. Epub 2018 Sep 19.
5
Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside.应对抗真菌药物耐药性的出现:来自实验室和临床的观点。
Future Microbiol. 2018 Aug;13(10):1175-1191. doi: 10.2217/fmb-2018-0059. Epub 2018 Aug 16.
6
Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together.欧洲医学真菌联合会改善全球患者护理和研究的全球指南和倡议:新领导层是要共同努力。
Mycoses. 2018 Nov;61(11):885-894. doi: 10.1111/myc.12836. Epub 2018 Aug 28.
7
Challenges in the diagnosis and treatment of mucormycosis.毛霉病诊断与治疗中的挑战。
Med Mycol. 2018 Apr 1;56(suppl_1):93-101. doi: 10.1093/mmy/myx101.
8
An aggressive multidisciplinary approach reduces mortality in rhinocerebral mucormycosis.积极的多学科方法可降低鼻脑型毛霉菌病的死亡率。
Surg Neurol Int. 2016 May 25;7:61. doi: 10.4103/2152-7806.182964. eCollection 2016.
9
Mucormycosis in Iran: a systematic review.伊朗的毛霉病:一项系统评价。
Mycoses. 2016 Jul;59(7):402-15. doi: 10.1111/myc.12474. Epub 2016 Feb 15.
10
Mucormycoses.毛霉病
Infect Dis Clin North Am. 2016 Mar;30(1):143-63. doi: 10.1016/j.idc.2015.10.011.